Cargando…
Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
Since the first description of the case of Auguste Deter, presented in Tübingen in 1906 by Alois Alzheimer, there has been an exponential increase in our knowledge of the neuropathological, cellular, and molecular foundation of Alzheimer's disease (AD). The concept of AD pathogenesis has evolve...
Autores principales: | Lazarczyk, Maciej J, Hof, Patrick R, Bouras, Constantin, Giannakopoulos, Panteleimon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523068/ https://www.ncbi.nlm.nih.gov/pubmed/23098093 http://dx.doi.org/10.1186/1741-7015-10-127 |
Ejemplares similares
-
Heterozygous Chorein Deficiency in Probable Tau-negative Early-onset Alzheimer Disease
por: Lazarczyk, Maciej J., et al.
Publicado: (2016) -
Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group
por: Perneczky, Robert, et al.
Publicado: (2016) -
Selective acquired long QT syndrome (saLQTS) upon risperidone treatment
por: Lazarczyk, Maciej Jakub, et al.
Publicado: (2012) -
White Matter Changes in Bipolar Disorder, Alzheimer Disease, and Mild Cognitive Impairment: New Insights from DTI
por: Xekardaki, Aikaterini, et al.
Publicado: (2011) -
No neuropathological evidence for a direct topographical relation between microbleeds and cerebral amyloid angiopathy
por: Kövari, Enikö, et al.
Publicado: (2015)